<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02502929</url>
  </required_header>
  <id_info>
    <org_study_id>15-164S-3</org_study_id>
    <secondary_id>5R01DK103663</secondary_id>
    <nct_id>NCT02502929</nct_id>
  </id_info>
  <brief_title>Diabetes Risk Reduction Through Eat, Walk, Sleep and Medication Therapy Management for Depressed Cambodians</brief_title>
  <acronym>DREAM</acronym>
  <official_title>Lifestyle and Medication Management to Lower Diabetes Risk in Severe Mental Illness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>UConn Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Khmer Health Advocates</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Penn State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>UConn Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of the study is to compare the effect of three different interventions on&#xD;
      lifestyle risk factors and biological risk factors for type 2 diabetes in depressed&#xD;
      Cambodians. The three different interventions are lifestyle, lifestyle plus medication&#xD;
      therapy management, and social services.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cambodian Americans have high risk for major depressive disorder and for type 2 diabetes.&#xD;
      Depression is a known risk factor for diabetes. Some antidepressants can also increase risk&#xD;
      of diabetes by causing weight gain. DREAM will test the effect of lifestyle and medication&#xD;
      therapy management (MTM) compared to social services (control) on diabetes risk among&#xD;
      depressed Cambodian Americans. Community health workers (CHWs) will deliver the lifestyle&#xD;
      intervention and assist pharmacists with MTM. Lifestyle and biological risk factors for&#xD;
      diabetes, such as depressive symptoms, HbA1c and insulin sensitivity, will be measured before&#xD;
      and after the interventions.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2015</start_date>
  <completion_date type="Actual">September 2020</completion_date>
  <primary_completion_date type="Actual">September 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lifestyle risk for type 2 diabetes</measure>
    <time_frame>12 months and 15 months</time_frame>
    <description>Change from baseline in depressive symptoms according to the Hopkins Symptom Checklist</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Biological risk for type 2 diabetes</measure>
    <time_frame>12 months and 15 months</time_frame>
    <description>Change from baseline in HbA1c and insulin resistance according to logHOMA-IR</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">182</enrollment>
  <condition>Diabetes</condition>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>Social Services</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants in this arm will receive referrals for social services as indicated.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lifestyle</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this arm will receive lifestyle modification from community health workers using the manualized lifestyle intervention called &quot;Eat, Walk, Sleep&quot;. They will receive individual home visits, health activity group sessions, and supportive phone calls.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lifestyle plus Medication Therapy Management</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this arm will receive everything in the Lifestyle arm, plus Medication Therapy Management (MTM). Participants will receive MTM from a pharmacist via telemedicine with the assistance of a community health worker.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Social Services</intervention_name>
    <arm_group_label>Social Services</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Lifestyle</intervention_name>
    <arm_group_label>Lifestyle</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Lifestyle Plus Medication Therapy Management</intervention_name>
    <arm_group_label>Lifestyle plus Medication Therapy Management</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Self-identified as Cambodian or Cambodian-American&#xD;
&#xD;
          -  Khmer speaking&#xD;
&#xD;
          -  Likely major depressive disorder&#xD;
&#xD;
          -  Elevated diabetes risk score per ADA guidelines&#xD;
&#xD;
          -  Ambulatory&#xD;
&#xD;
          -  Competent to give consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy or plans to become pregnant in the next 2 years&#xD;
&#xD;
          -  Previous diagnosis of diabetes&#xD;
&#xD;
          -  Seeing or hearing problems that would interfere with group sessions&#xD;
&#xD;
          -  Currently being followed by a physician for major medical problem&#xD;
&#xD;
          -  Serious thinking or memory problems (e.g., schizophrenia or dementia)&#xD;
&#xD;
          -  3 or more days in a psychiatric hospital or self-harm in the past 2 years.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julie A Wagner, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UConn Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Uconn Health</name>
      <address>
        <city>Farmington</city>
        <state>Connecticut</state>
        <zip>06030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Khmer Health Advocates</name>
      <address>
        <city>West Hartford</city>
        <state>Connecticut</state>
        <zip>06110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center for Southeast Asians</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02907</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>July 16, 2015</study_first_submitted>
  <study_first_submitted_qc>July 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 20, 2015</study_first_posted>
  <last_update_submitted>February 2, 2021</last_update_submitted>
  <last_update_submitted_qc>February 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>UConn Health</investigator_affiliation>
    <investigator_full_name>Julie A. Wagner</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <keyword>Depression</keyword>
  <keyword>Medication therapy management</keyword>
  <keyword>Community health workers</keyword>
  <keyword>Cambodian</keyword>
  <keyword>Refugee</keyword>
  <keyword>Prevention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Depression</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

